chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red dots on upper arms and upper legs; Skin was itchy on both arms / waist / back / leg; Sting sunburn; Patient could not think / sharpness was gone; red dots on arm; Rash on trunk / under breast; Bad flu; Chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Bad flu), PRURITUS (Skin was itchy on both arms / waist / back / leg), SUNBURN (Sting sunburn), MEMORY IMPAIRMENT (Patient could not think / sharpness was gone) and ERYTHEMA (Red dots on upper arms and upper legs) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 22-Apr-2021 at 12:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 22-Mar-2021, the patient experienced CHILLS (Chills) and FATIGUE (fatigue). On 22-Apr-2021, the patient experienced INFLUENZA (Bad flu). On 24-Apr-2021, the patient experienced RASH (Rash on trunk / under breast) and ALLERGY TO VACCINE (red dots on arm). On 26-Apr-2021, the patient experienced PRURITUS (Skin was itchy on both arms / waist / back / leg), SUNBURN (Sting sunburn) and MEMORY IMPAIRMENT (Patient could not think / sharpness was gone). On an unknown date, the patient experienced ERYTHEMA (Red dots on upper arms and upper legs). On 24-Mar-2021, CHILLS (Chills) outcome was unknown. On 29-Mar-2021, FATIGUE (fatigue) outcome was unknown. On 25-Apr-2021, ALLERGY TO VACCINE (red dots on arm) outcome was unknown. At the time of the report, INFLUENZA (Bad flu), PRURITUS (Skin was itchy on both arms / waist / back / leg), SUNBURN (Sting sunburn), MEMORY IMPAIRMENT (Patient could not think / sharpness was gone), ERYTHEMA (Red dots on upper arms and upper legs) and RASH (Rash on trunk / under breast) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
2 weeks after vaccination tingling and numbness in tips of fingers and toes - gradually spreading up hands and feet over course of several months - eventually started IVIG treatments that reduce symptoms temporarily.
fever of 102 beginning 8hrs p/vax & cont x24hrs (did not stay @ 101 but was feverish);redness & swelling @ site of Td inj
the evening I had a headache, chills, temp 103, and major major sick, stayed in bed. my fever didn't break until the next night. Then that evening my neck popped and my lymph nodes started swelling up and I went to the hospital and it was related to the vaccine. The second vaccine I had chills and sore arm but nothing like first dose.
CDC reports: 2 yo child developed fever to 104, diarrhea & vomiting following DTP/OPV/HIB immunization. Duration of illness 7 days.
pt recvd vax 13JUN95 & 21JUN95 devel a macular/papular rash on trunk w/2 vesicular lesion & a fever;
Initial case report received from a health care professional via Med Como, on 13 NOV 2009. A 62-year-old female patient was vaccinated with FLUVIRIN (batch no. unknown) on 03 NOV 2009. 24 hours after vaccination the patient experienced numbness and tingling of the lower extremities radiation down to her toes. On 06 NOV 2009 the events were ongoing. The outcome was not reported. MedCom reference no.: NA09-005088. Addendum: According to medical assessment, the case was set not serious. This case was already reported as MA2009-4306. Follow up report received from a Physician on 22 Feb 2010: This polymedicated patient with multiple family history experienced fatigue and decreased appetite on 10 Nov 2009, dizziness and dyspnoea on 19 Nov 2009. The patient reported that she felt prickling and burning sensation remains in her legs, thighs and torso, the upper extremities were free of symptoms. The symptoms were most notable when she goes to bed. The outcome of the events were not reported.
4 days: fever, chills, weakness. Painful eyelids. Red welts/white pustules on back/chest.
SHOB, sore, red, warm, swollen area of left upper arm that lasted 1 1/2 weeks.
Moderna Vaccine 3:30am, chills, fatigue, muscle aches, low grade fever, slight headache lasting for 24 hours post-dose
Swelling and redness at injection site, such as in an allergic reaction, 3-4 in diameter.
Hives, facial swelling, leg pain, stiffness, redness at site of DTaP.
erythema and swelling around injection site of DTap (left thigh) measuring 2 in X 2 in
upper right arm is hurting; Upper right arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of   in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.            No concomitant medications were provided.  No treatment information provided.
Information has been received from a registered nurse concerning a 54 year old female employee who on 05-JUN-2006 was vaccinated in the right upper arm with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). In the morning of 06-JUN-2006, 24 hours after vaccination, the patient presented to the physician's office with a diffuse rash to her forearm and left upper thigh. There were no effects, swelling, or redness at the injection site. It was known if the event was related to therapy with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Additional information has been requested.
Pt presented for their second dose of their COVID-19  vaccine on 04/13/2021.  Pt had received Pfizer first dose on 03/24/2021 Lot #EP7534.  Pt inaccurately received a dose of the Moderna vaccine Lot #038B21A at approximately 0915.  Pt was sent out to the mandatory 15min observation during which he realized he was given the incorrect dose.  Pt denies signs/symptoms of allergic reaction or any other adverse side effects at this time. Pt completed the 15 minute waiting period, was seen by an MD on site as well as the vaccination site manager. The pt requested follow-up from the local public health department.
A few minutes after receiving vaccine heart began racing, face went numb, tingly in mouth and throat. EpiPen was administered and then transferred to ED via ambulance.
Loss of muscle control in throat, was not able to swallow, tongue and throat had burning feeling, body had itchy feeling (slight).
6y.o. male with no significant PMH presented with progressive worsening of fever, chills, vomiting, myalgias, chest pain, abdominal pain, dizziness, weakness since Saturday. Initial symptoms were cough and congestion. Wet cough not in bouts present throughout the day. Since Monday, started having worsening fatigue, chest pain and vomiting. Vomiting was NBNB, projectile, 3-4 episodes following feeds. Chest pain is intermittent, diffuse, non radiating.  Fever started since tuesday, last Tmax was yesterday morning 102.8 F relieved after giving Tylenol. Patient tested positive for COVID-19 on Sunday. Patient was given ampicillin. He admitted to the floors for definitive management. Initial physical examination on the
FLU LIKE SYMPTOMS; This spontaneous report received from a parent concerned a 19 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 26-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 26-JUL-2021, the subject experienced flu like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from flu like symptoms. This report was non-serious. This case, from the same reporter is linked to 20210757738.
Information has been received from physician concerning an male infant who on 13-AUG-2007 was vaccinated with his first oral dose of ROTATEQ (Lot number was not known). On 15-AUG-2007 the patient developed diarrhea. The patient sought medical attention by contacting the physician and an office visit. The patient's diarrhea persisted. There was no product quality complaint. No other information was available from the physician. Additional information has been requested.
pt recvd vax 115Pm via immun clinic;pt returned to clinic w/mom p/exp intense itching (entire body) w/raised welts; pt was given DPH & VS monitored; sent home when stable per MD
Information has been received from a physician concerning a 15 year old female who on an unspecified date was vaccinated with the second dose of GARDASIL (Lot # not reported). One week after receiving the second dose the patient experienced nerve pain in the arm that GARDASIL was given, what specific arm unspecified, and the patient was still experiencing the nerve pain at the reporting time. Additional information has been requested.
Anaphylaxis: diffuse erythema and urticarial, facial swelling, vomiting, lethargy, perioral cyanosis
mild fever; chills; This is a spontaneous report received from a contactable reporter(s) (Physician) this physician reported for a female (patient).  A 58 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 19Oct2021 13:00 (Lot number: 301558A) at the age of 58 years as dose 1, 0.3 ml single for covid-19 immunisation. Relevant medical history included: "hypertension" (ongoing); "osteoarthritis" (ongoing); "prediabetes" (ongoing); "Allergic reactions" (ongoing); "hypercholesterolemia" (ongoing). Concomitant medication(s) included: LIPITOR taken for blood cholesterol increased (ongoing); HYDROCHLOROTHIAZIDE taken for hypertension (ongoing); ALLEGRA taken for hypersensitivity (ongoing). The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "mild fever"; CHILLS (non-serious) with onset 2021, outcome "recovered" (2021), described as "chills".  Additional Information: Did the patient provide information to you regarding the reported adverse event (s) with the use of the product was reported as yes. If Yes above, do you consider the Pfizer product had a causal effect to the adverse event was reported as yes. Patient received the first single dose of vaccine on 19Oct2021 13:00 as dose 1single Anatomical Site of injection: Left upper arm. The night of the second vaccine she reported she had mild fever and chills which is the same side effects she had after the first dose. Had mild fever, chills, night of vaccine administration. These symptoms will similar to what site had experienced after first dose of Pfizer covid vaccine one month earlier symptoms resolved next day.  No follow-up attempts are possible. No further information is expected.
Shingles - Herpes Zoster; This is a spontaneous report received from a contactable consumer or other non hcp. A 39-years-old female patient received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EL9266), via an unspecified route of administration on 12Feb2021 09:00,at the age of 39 years old, as Dose 1,single for covid-19 immunization.Medical history included parkinson's disease, thyroiditis, cholecystectomy from an unknown date and unknown if ongoing. Concomitant medications included cetirizine hydrochloride (ZYRTEC ALLERGY) taken for an unspecified indication, start and stop date were not reported.The patient experienced shingles- herpes zoster on 22Apr2021.Therapeutic measures were taken as a result of shingles - herpes zoster.The outcome of the events was not recovered.The patient received Valacyclovir as treatment.The patient had not received any other vaccines within 4 weeks.The patient was not diagnosed with covid prior to vaccination and not tested post vaccination.The patient reported no allergies.  No follow up attempts are needed: No further informations are expected.
17 year old recevied vaccine; A spontaneous report as received from a pharmacist concerning a 17-year-old, male patient, who received Moderna COVID-19 vaccine and considered as product administered to patient of inappropriate age .   The patient's had no known past medical history of drug addiction or an adverse reactions to vaccines. Concomitant medications were not provided.   On 22 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number:010M20A) through intramuscular route in the right deltoid for prophylaxis of COVID-19 infection.   No treatment information was provided.   Lab details were not provided.  Action taken with mRNA-1273 in response to the event was not applicable  The outcome of inappropriate age at vaccination administration was considered resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273.  There were no reported adverse events associated with this case.
On 11/7 had flu vaccine. On 11/8 brought by pneumoia post grand mal episode. Brain CT, cardiac w/u neg. Observed for 24 hours no previous episodes.
Initially severe covid symptoms, requiring a covid test, extremely large cyst on upper right eye lid, breathing difficulties, headaches and arm pain. Required treatment for asthma and Long Haulers, required patient to need extra breathing treatments and use of in-haler. Patient unaware she had a UTI which quickly impacted her kidneys. Headaches, arm pain and breathing troubles continue.
Facial swelling approx. 16 hours after 2nd dose. Zyrtec and supportive cares given, to monitor at home at this time.
Persisting rash on inner left arm and inner right thigh; This is a spontaneous report received from a contactable consumer (Patient). A 29-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Batch/Lot number was not reported), via an unspecified route of administration on 05Apr2021 single dose for covid-19 immunisation. Medical history included hyperthyroidism. Patient had no known allergies. There were no concomitant medications (No other medications in two weeks). Patient historic vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported) for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. On 07Apr2021, the patient experienced persisting rash on inner left arm and inner right thigh. No treatment was received due to adverse events. The event was Recovered/Resolved with Sequel on an unspecified date in 2021.
patient originally schedule to receive 1st dose of pfizer vaccine however they ended up receiving moderna and their scheduled appt for the 2nd dose was not changed so they got the 2nd dose at 3 weeks instead of 4 weeks.
Information has been received from a RN concerning a 35 yr old male who on 12/15/1998 and 03/09/1998 was vaccinated with the first and second doses of varicella virus.  On May 13, 1999 laboratory evaluation revealed a lack of response.
I contracted Covid-19, testing positive on a rapid antigen test, and on a PCR test two days later. Symptoms were mild: initially chills, low-grade fever, body aches. These subsided after a day. Subsequently: sore throat for about a week. About a week and a half later, a slight cough that lingered into March (may be unrelated?). I am filling out this form at the request of V-Safe, and do not consider the adverse effect to be caused by the vaccine.
pt recvd vax; lt arm swelled & turned red; seen urgent care; put on dicloxicillin; somewhat better;
Mom reports for 24 hours after receiving Fluarix vaccine the following symptoms: complained her body hurt, no fever, projectile vomited 10 times, laid around, and was fussy. After 24 hours she returned to her base line.
Information has been received from a 90 year old female with a history of dizzy spells and no known allergies who on 12-JUL-2007 was vaccinated (reported as oral) with a 0.65 ml dose of Zostavax (Oka/Merck).  Concomitant therapy included fenofibrate, BONIVA and CLARITIN.  On 16-JUL-2007 the patient developed dizziness, and "not feeling like herself".  Medical attention was not sought.  At the time of this report the patient had not recovered.  No further information was provided.  There was no product quality complaint involved.  Additional information has been requested.  It was also noted that the patient experienced an adverse event after therapy with alendronate sodium (MSD) (WAES#0708USA01689).
This spontaneous report as received from a medical assistant (other health professional) refers to unspecified number of patients of unknown age. Pertinent medical histories and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored GARDASIL 9, 1 DF intramuscularly for prophylaxis. Temperature excursion 32 to 35 degree Fahrenheit for 5 minutes and 47 to 77 Fahrenheit for 17 minutes. No adverse reactions (no adverse event) per primary reporter. No further information to report. This is one of the several reports from same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA001928:Original Case: 1706USA001387: US-009507513-1706USA001927:Original Case: 1706USA001387: US-009507513-1706USA001929:Original Case: 1706USA001387.
Beginning the second day following vaccination to current  day, I have the following symptoms:  a stiff neck, severe headache, brain fog, and highly disturbed sleep.,
A report has been received from a physician concerning an 8 month old other, female subject, Height 57.5 inches; Weight: 82.0 pounds, who had been receiving FLUMIST (Intranasal), 0.5 mg/ml, once for flu. FLUMIST (Intranasal) started on 23-Sep-2013 for flu. The patient experienced sneezing/sneezes ten times after spray which started on 23-Sep-2013. FLUMIST (Intranasal) was discontinued on 23-Sep-2013. The outcome of the event of sneezing/sneezes ten times after spray is unknown. The report was considered to be non-serious.
Patient called pharmacy & spoke with employee. - Employee said that patient received a flu shot from a floater in the store on 9/8/11. She said the needle was in patient for an usually longtime (approx 10 seconds) her deltoid muscle is sore when she extends her arm fully & painful to the touch.
heart murmur; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78-year-old female patient received BNT162b2 (BNT162B2), on 25Mar2021 as dose 2, single (Lot number: ER8730) at the age of 77 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis in knees" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "Low vitamin D3" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "acid reflux" (unspecified if ongoing). Concomitant medication(s) included: SIMVASTATIN taken for blood cholesterol (ongoing); VITAMIN D3 1000 taken for vitamin d deficiency (ongoing); REPLESTA oral taken for vitamin supplementation; PANTOPRAZOLE taken for gastrooesophageal reflux disease (ongoing); LOSARTAN taken for blood pressure measurement (ongoing). Vaccination history included: BNT162b2 (Dose 1; lot number: EN6203, left arm), administration date: 02Mar2021, when the patient was 77-year-old, for COVID-19 immunization. The following information was reported: CARDIAC MURMUR (non-serious) with onset Apr2021, outcome "unknown", described as "heart murmur". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Patient did an EKG before surgery and that was fine. They thought she had a heart murmur last Apr2021 and she had a workup that was perfect. They did pictures, ultrasounds and put dye through her and she knows she is ok on all that. Had an MRI to see if her other breast is ok and that is fine that was just a week before the surgery. They wanted to see what they are dealing with. Her mammogram last Jul2021 was fine, it said she has dense breasts but didn't show anything and she has always had dense breasts.  Follow-Up (06Oct2022): Follow-up attempts are completed. No further information is expected.
Shingles; This case was reported by a nurse via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. Chat with RN how long should a person wait with active shingles to get their 2nd shingrix. The reporter didn't have facts with this patient, this was only what he was telling me. The patient might be confusing the zostavax with the shingrix, the reporter would be looking into that. HCP disconnected from the chat and therefore no permission given to follow up.
This is a spontaneous report from a contactable other hcp reported for herself.   A 30-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 30 years old, intramuscularly administered in Arm Left on 23Mar2021 09:00 AM (Lot Number: EN5318), at single dose for covid-19 immunisation.    Medical history included Repaired coarctation of the aorta, bicuspid aortic valve, dilated ascending aorta from an unknown date and unknown if ongoing, Allergies to Sulfa drugs and propranolol. The patient previously received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EN5318), at the age of 30 years old, intramuscularly administered in Arm Left on 02Mar2021 10:15 AM, at single dose for covid-19 immunisation.   Concomitant medications received within 2 weeks of vaccination included arginine hydrochloride, ascorbic acid, calcium, calcium pantothenate, cyanocobalamin, ferrous fumarate, folic acid, magnesium, methionine, nicotinic acid, phosphorus, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, thiamine hydrochloride, tocopheryl acetate, triticum aestivum, zinc (MULTI VITAMIN), magnesium, fish oil, fexofenadine hydrochloride (ALLEGRA) as needed, all taken for an unspecified indication, start and stop date were not reported.  The patient experienced Chills, sweats, body aches, headache, fever, all on 23Mar2021 with outcome of recovered on unknown date.  No treatment received for the adverse events.   No any other vaccines received within 4 weeks prior to the COVID vaccine, and Prior to vaccination, the patient was not diagnosed with COVID-19, has not been tested for COVID-19.   No follow-up attempts possible. No further information expected.
Information has been received from a healthcare worker, office manager who reported that doses of VARIVAX (Merck) (lot # K010438, expired date 22-JUL-2016; lot # K021486, expired date 03-NOV-2016; lot # K003423, expired date 16-MAR-2016; lot # L004655, expired date 11-FEB-2017; lot # K026385, expired date 15-DEC-2016; lot # L010144, expired date 24-MAR_2017), which were exposed to temperature outside of the recommended range, were administered to unspecified patients on unspecified dates since 30-JUN-2015 (dose, frequency and route were not provided). No adverse effects were reported. This is one of two reports received from the same source. Additional information has been requested.
Pt reported dizziness, nausea & weakness x 2 days. He did not like the HIGH DOSE FLUZONE.